ArticleJournal of clinical and diagnostic research : JCDR2014
Incidence of multidrug resistant pseudomonas aeruginosa isolated from burn patients and environment of teaching institution.
Article in Journal of clinical and diagnostic research : JCDR, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 64 citations in OpenAlex.
- Detection and Antimicrobial Susceptibility of Carbapenem-Resistant Organisms Isolated in the Center of Care and Protection of Orphan Children, Vietnam.International journal of microbiology · 2025Article
- Antimicrobial resistance profile, biofilm forming capacity and associated factors of multidrug resistance in Pseudomonas aeruginosa among patients admitted at Tikur Anbessa Specialized Hospital and Yekatit 12 Hospital Medical College in Addis Ababa, Ethiopia.BMC infectious diseases · 2024Article
- Complementary supramolecular drug associates in perfecting the multidrug therapy against multidrug resistant bacteria.Frontiers in immunology · 2024Article
- Comparison of Antibiofilm Activity ofMicroorganisms · 2023Article
- Tazobactam/ceftolozane and tobramycin combination therapy in extensively drug-resistant Pseudomonas aeruginosa infections in severe burn injury: a case report.Journal of pharmaceutical health care and sciences · 2023Article
- Ginger-Enriched Honey Attenuates Antibiotic ResistantAntibiotics (Basel, Switzerland) · 2023Article
- Validated Preclinical Mouse Model for Therapeutic Testing against Multidrug-Resistant Pseudomonas aeruginosa Strains.Microbiology spectrum · 2022Article
- Multidrug-Resistant and Extremely Drug-ResistantTurkish journal of pharmaceutical sciences · 2022Article
- New Variants of PseudomonasMicroorganisms · 2022Article
- Bacteria from bovine clinical mastitis showed multiple drug resistance.Veterinary research communications · 2022Article
- Isolation, characterization, and effectiveness of bacteriophage Pɸ-Bw-Ab against XDRIranian journal of basic medical sciences · 2021Article
- Molecular characterization of clinical and environmentalSaudi journal of biological sciences · 2019Article
- High incidence of type III secretion system associated virulence factors (exoenzymes) in Pseudomonas aeruginosa isolated from Iranian burn patients.BMC research notes · 2019Article
- Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption.Revista da Sociedade Brasileira de Medicina Tropical · 2019Article
- Investigation of antimicrobial susceptibility, class I and II integrons among Pseudomonas aeruginosa isolates from hospitalized patients in Isfahan, Iran.BMC research notes · 2018Article
- Adjuvant Antibiotic Activity of Acidic Sophorolipids with Potential for Facilitating Wound Healing.Antimicrobial agents and chemotherapy · 2017Article
- Extended spectrum and metalo beta-lactamase producing airborneAntimicrobial resistance and infection control · 2017Article
- Distribution of the Strains of Multidrug-resistant, Extensively Drug-resistant, and Pandrug-resistantAdvanced biomedical research · 2017Article
- Development and evaluation of murine lung-specific disease models for Pseudomonas aeruginosa applicable to therapeutic testing.Pathogens and disease · 2015Article
- The Effects of Berberine and Palmatine on Efflux Pumps Inhibition with Different Gene Patterns inAvicenna journal of medical biotechnologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextPseudomonas aeruginosa is an important pathogen which causes nosocomial infections in immunocompromised patients, especially in hospitalized burn patients. In recent times, it has emerged as a widespread Multi Drug Resistant (MDR) pathogen which requires antibiotic susceptibility testing on a regular as well as a periodic basis. AIM OF THE STUDY: The present study was undertaken to determine the antibiogram of P. aeruginosa which was isolated from inpatients and environmental sources, and to type the strains, based on their antibiogram patterns. SETTINGS AND
designA prospective study was undertaken with 525 samples (blood and wound swabs) which were taken from 60 patients who were admitted to Vardhman Mahavir Medical College and Safdarjang hospital with burn injuries and with 101 samples which were obtained from environmental sources viz. surgical instruments, dressings, suction devices, sinks, antiseptic solutions, etc. MATERIALS AND
methodsThe strains were cultured and identified by standard microbiological techniques and Kirby- Bauer disc diffusion antibiotic susceptibility testing was done for each. STATISTICAL ANALYSIS: Chi -squire tests were done and p- values of less than 0.05 were considered to be significant.
resultsFifty six strains and two strains, respectively, of P. aeruginosa were isolated from inpatients and environmental samples (one strain from sink and one strain from door wall, among the two) respectively. In total, 58 (81%) P. aeruginosa strains were found to be resistant to aminoglycosides, 41-70% were resistant to beta-lactams - piperacillin, ceftazidime, and aztreonam, 34.5% were resistant to piperacillin-tazobactam, 12.06% were resistant to ciprofloxacin and 13-19% were resistant to carbapenems. All strains were sensitive to colistin. P. aeruginosa was resistant to three of the four 'in-use' drugs i.e. piperacillin+tazobactam, imipenem, ceftazidime, and gentamicin, which was taken as MDR, which depicted MDR percentage as 36.2 (21/58).
conclusionStrategies of optimal prescribing, including control of antibiotic usage, coupled with periodic studies on MDR P. aeruginosa infections in burn patients, appear to be leading priorities which help in improving therapeutic gains in such patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.